封面
市場調查報告書
商品編碼
1424327

生物模擬市場:按產品/服務、按應用、按分銷管道、按地區

Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球生物模擬市場預計將從 2023 年的 19.019 億美元增至 2030 年的 58.944 億美元,預測期內複合年成長率為 17.5%。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 19.019 億美元
實際資料 2018-2021 預測期 2023-2030
預測期2023/2024~2030/2031年複合成長率: 17.50% 2030/2031 年預測值 58.944 億美元
圖 1. 2023 年按地區分類的生物模擬全球市場佔有率(%)
生物模擬市場-IMG1

生物模擬是一種利用電腦模擬來模擬人體生物過程、系統和途徑的計算模型。它幫助我們了解人體在分子和細胞層面上如何運作,以及某些醫療干預措施(例如藥物和醫療設備)如何發揮作用。透過在從分子到組織層級的多個尺度上模擬疾病機制、進展以及與治療性介入的相互作用,生物模擬減少了藥物開發過程中對廣泛實驗室和臨床試驗的需求。很有幫助。這降低了成本、提高了效率並加速了藥物研發。

市場動態:

全球生物模擬市場的成長是由製藥和生物技術行業研發支出的增加、對降低藥物開發成本和開發時間的日益重視、個人化醫療的日益採用、慢性病的流行等因素推動的。隨著技術的快速進步。然而,由於缺乏處理複雜的生物模擬工具和模型所需的合格的IT基礎設施和熟練的專業人員,市場成長可能會受到限制。這個市場的主要商機是由於技術的進一步進步,生物模擬的應用領域不斷擴大,例如疫苗開發、用餐和毒理學分析、組織工程和個人化醫療,以及工業和學術機構。他們之間持續的合作關係。

近年來,全球生物模擬市場取得了重大技術進步,提供了新的機會和應用。生物模擬是利用電腦建模和模擬來研究和預測生物過程。這使得研究人員能夠模擬細胞、組織和整個生物體等生物系統,以便更好地了解疾病並測試新的藥物治療方法。

本研究的主要特點

  • 該報告對全球生物模擬市場進行了詳細分析,並提供了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率(CAGR%)。
  • 它還揭示了各個細分市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球生物模擬市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球生物模擬市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球生物模擬市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球生物模擬市場 -冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第 5 章 全球生物模擬市場,依產品與服務分類,2018-2030 年

  • 軟體
  • 服務

第6章 全球生物模擬市場,依應用分類,2018-2030

  • 藥物研發
  • 藥物開發

第7章 全球生物模擬市場,依通路,2018-2030

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章全球生物模擬市場,按地區,2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章 競爭形勢

  • Certara, LP
  • Simulations Plus, Inc.
  • Dassault Systemes(Accelrys)
  • Genedata AG
  • LeadScope, Inc.
  • Compugen Inc.
  • Schrodinger, LLC
  • In Silico Biosciences, Inc.
  • Advanced Chemistry Development, Inc.
  • Chemical Computing Group ULC
  • Physiomics PLC
  • Pharmaceutical Product Development, LLC(Evidera)

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI2016

Global Biosimulation Market is expected to reach US$ 5,894.4 Mn by 2030, from US$ 1,901.9 Mn in 2023, exhibiting a CAGR of 17.5% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 1,901.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 17.50% 2030/2031 Value Projection: US$ 5,894.4 Mn
Figure 1. Global Biosimulation Market Share (%), By Region, 2023
Biosimulation Market - IMG1

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics:

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study:

  • This report provides in-depth analysis of the global biosimulation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Biosimulation Market Detailed Segmentation:

  • By Product and Services
    • Software
    • Services
  • By Application
    • Drug Discovery
    • Drug Development
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top companies in Global Biosimulation Market
    • Certara, L.P.
    • Simulations Plus, Inc.
    • Dassault Systemes (Accelrys)
    • Genedata AG
    • LeadScope, Inc.
    • Compugen Inc.
    • Schrodinger, LLC
    • In Silico Biosciences, Inc.
    • Advanced Chemistry Development, Inc.
    • Chemical Computing Group ULC
    • Physiomics PLC
    • Pharmaceutical Product Development, LLC (Evidera)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Biosimulation Market Snippet, By Product and Services
    • Global Biosimulation Market Snippet, By Application
    • Global Biosimulation Market Snippet, By Distribution Channel
    • Global Biosimulation Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biosimulation Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biosimulation Market, By Product and Services, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Biosimulation Market, By Application, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Biosimulation Market, By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Biosimulation Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Certara, L.P.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Simulations Plus, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dassault Systemes (Accelrys)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Genedata AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • LeadScope, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Compugen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schrodinger, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • In Silico Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced Chemistry Development, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Chemical Computing Group ULC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Physiomics PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pharmaceutical Product Development, LLC (Evidera)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us